Sobi Reaps Benefits From Acquisitions, Commercial Focus
Revenues Grew By 56% In 2019
Sweden’s mid-sized pharmaceutical company, Swedish Orphan Biovitrum, has expanded into hematology and strengthened its immunology business, growing its top and bottom lines in 2019.
